Increasing trends in Schedule II opioid use and doctor shopping during 1999-2007 in California†

Pharmacoepidemiology and Drug Safety

Volumn 23, Issue 1, 2014, Pages 26-35

  Han, Huijun ^a,d   Kass, Philip H ^a   Wilsey, Barth L ^b,c   Li, Chin Shang ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Age; California; Doctor shopping; Gender; Opioid prescription; Pharmacoepidemiology; Prevalence

Indexed keywords

FENTANYL; HYDROMORPHONE; LEVORPHANOL; METHADONE; MORPHINE; OPIATE; OXYCODONE; PETHIDINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DRUG USE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; PHYSICIAN; POPULATION; PRESCRIPTION; PRESCRIPTION DRUG DIVERSION; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SHOPPING; TREND STUDY; UNITED STATES; YOUNG ADULT;

AGE; CALIFORNIA; DOCTOR SHOPPING; GENDER; OPIOID PRESCRIPTION; PHARMACOEPIDEMIOLOGY; PREVALENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CALIFORNIA; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PHYSICIAN'S ROLE; PRESCRIPTION DRUG MISUSE; YOUNG ADULT;

EID: 84891614543     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3496     Document Type: Article

References (34)

1. Volkow ND, McLellan TA. Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. JAMA 2011; 305(13): 1346-7.
2. National drug intelligence center. National Drug Threat Assessment. 2009. Johnstown, Pennsylvania; 2008.
3. Government Accountability Office. Medicare Part D: Instances of Questionable Access to Prescription Drugs; 2011.
4. Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008; 300(22): 2613-20.
5. Martyres RF, Clode D, Burns JM. Seeking drugs or seeking help? Escalating "doctor shopping" by young heroin users before fatal overdose. Med J Aust 2004; 180(5): 211-4.
6. Simoni-Wastila L, Tompkins C. Balancing diversion control and medical necessity: the case of prescription drugs with abuse potential. Subst Use Misuse 2001; 36(9-10): 1275-96.
7. Parente ST, Kim SS, Finch MD, Schloff LA, Rector TS, Seifeldin R, et al. Identifying controlled substance patterns of utilization requiring evaluation using administrative claims data. Am J Manag Care 2004; 10(11 Pt 1): 783-90.
8. Katz N, Panas L, Kim M, Audet AD, Bilansky A, Eadie J, et al. Usefulness of prescription monitoring programs for surveillance-analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006. Pharmacoepidemiol Drug Saf 2010; 19(2): 115-23.
9. White AG, Birnbaum HG, Schiller M, Tang J, Katz NP. Analytic models to identify patients at risk for prescription opioid abuse. Am. J. Manag. Care 2009; 15(12): 897-906.
10. Wilsey BL, Fishman SM, Gilson AM, Casamalhuapa C, Baxi H, Lin TC, et al. An analysis of the number of multiple prescribers for opioids utilizing data from the California Prescription Monitoring Program. Pharmacoepidemiol. Drug Saf. 2011; 20(12): 1262-8.
11. Wilsey BL, Fishman SM, Gilson AM, Casamalhuapa C, Baxi H, Zhang H, et al. Profiling multiple provider prescribing of opioids, benzodiazepines, stimulants, and anorectics. Drug Alcohol Depend 2010; 112(1-2): 99-106.
12. Peirce GL, Smith MJ, Abate MA, Halverson J. Doctor and pharmacy shopping for controlled substances. Med Care 2012; 50(6): 494-500.
13. Gilson AM, Fishman SM, Wilsey BL, Casamalhuapa C, Baxi H. Time series analysis of California's prescription monitoring program: impact on prescribing and multiple provider episodes. J Pain 2012; 13(2): 103-11.
14. Han H, Kass PH, Wilsey BL, Li CS. Individual and county-level factors associated with use of multiple prescribers and multiple pharmacies to obtain opioid prescriptions in California. PLoS One 2012; 7(9): e46246.
15. Population Division of U.S. Census Bureau. State Single Year of Age and Sex Population Estimates: April 1, 2000 to July 1, 2009 - RESIDENT. In; 2010.
16. Korff MV, Saunders K, Thomas Ray G, Boudreau D, Campbell C, Merrill J, et al. De facto long-term opioid therapy for noncancer pain. Clin J Pain 2008; 24(6): 521-7.
17. Campbell CI, Weisner C, Leresche L, Ray GT, Saunders K, Sullivan MD, et al. Age and gender trends in long-term opioid analgesic use for noncancer pain. Am J Public Health 2010; 100(12): 2541-7.
18. Franklin GM, Mai J, Wickizer T, Turner JA, Fulton-Kehoe D, Grant L. Opioid dosing trends and mortality in Washington State workers' compensation, 1996-2002. Am J Ind Med 2005; 48(2): 91-9.
19. Sullivan MD, Edlund MJ, Fan MY, Devries A, Brennan Braden J, Martin BC. Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study. Pain 2008; 138(2): 440-9.
20. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol. Drug Saf. 2009; 18(12): 1166-75.
21. American Chronic Pain Association. Coping with chronic pain. In; 1995.
22. National Center for Health Statistics. Health, United States, 2006, Special feature on pain with chartbook on trends in the health of Americans. 2006.
23. Institute of Medicine. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. In. Washington, DC: The National Academies Press; 2011.
24. Freburger JK, Holmes GM, Agans RP, Jackman AM, Darter JD, Wallace AS, et al. The rising prevalence of chronic low back pain. Arch Intern Med 2009; 169(3): 251-8.
25. Braden JB, Fan MY, Edlund MJ, Martin BC, DeVries A, Sullivan MD. Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study. J. Pain 2008; 9(11): 1026-35.
26. American Academy of Pain Medicine and American Pain Society. The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin. J. Pain 1997; 13(1): 6-8.
27. American Society of Anesthesiologists. Practice guidelines for chronic pain management. A report by the American Society of Anesthesiologists Task Force on Pain Management, Chronic Pain Section. Anesthesiology 1997; 86(4): 995-1004.
28. Medical Board of California. Guidelines for prescribing controlled substances for pain (Adopted unanimously by the Medical Board on July 29, 1994.and August 1, 2003). In; 2003.
29. The Board of Pharmacy of California. Prescribing and dispensing controlled substance prescription forms (Timeline for Major Changes to California Prescribing Laws). In.
30. RD Helme, SJ Gibson 8 Pain in Older People. In Epidemiology of Pain Seattle, IK Crombie (ed.). WA: IASP Press, 1999; pp. 103-112.
31. Substance Abuse and Mental Health Services Administration OoAS. Results from the 2007 National Survey on Drug Use and Health: National Findings In. Rockville, MD; 2008
32. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 2010; 152(2): 85-92.
33. National Center for Injury Prevention and Control CfDCaP. Unintentional drug poisoning in the United States In; 2010.
34. G Lacy News release: brown to launch online technology to fight prescription drug abuse. In; 2008.